Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000554717 | SCV000650927 | uncertain significance | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2017-07-12 | criteria provided, single submitter | clinical testing | In summary, this variant is a novel in-frame duplication change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the duplicated amino acids is currently unknown. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a FLNC-related disease. This sequence change inserts 9 nucleotides in exon 12 of the FLNC mRNA (c.1945_1953dupATCCGAGAC). This leads to the duplication of 3 amino acid residues in the FLNC protein (p.Ile649_Asp651dup) but otherwise preserves the integrity of the reading frame. |